• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA WITH BD CONNECTA AND BD Q-SYTE; INTERVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA WITH BD CONNECTA AND BD Q-SYTE; INTERVASCULAR CATHETER Back to Search Results
Catalog Number 383661
Device Problem Microbial Contamination of Device (2303)
Patient Problems Unspecified Infection (1930); Skin Inflammation (2443)
Event Date 07/22/2019
Event Type  Injury  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that medical intervention occurred during use with a bd nexiva with bd connecta and bd q-syte.The following information was provided by the initial reporter, "recurrent observation of inflammatory puncture sites or even infection following the use of bd nexiva catheters by the only department usually using this type of medical device in our establishment, and this despite compliance with the rules of asepsis and different fdi.Several inflammatory punctures and an infection with s.Aureus methis requiring a surgical cleaning procedure.".
 
Event Description
It was reported that medical intervention occurred during use with a bd nexiva with bd connecta and bd q-syte.The following information was provided by the initial reporter, "recurrent observation of inflammatory puncture sites or even infection following the use of bd nexiva catheters by the only department usually using this type of medical device in our establishment, and this despite compliance with the rules of asepsis and different fdi.Several inflammatory punctures and an infection with s.Aureus methis requiring a surgical cleaning procedure.".
 
Manufacturer Narrative
H.6.Investigation: a device history review was conducted for lot number 8058799.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.Additionally, a sample could not be obtained for evaluation and testing, but this lot was treated and received a certificate of conformance for sterility.Unfortunately, without the ability to investigate the affected unit our quality engineers were unable to determine the root cause for this complaint.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA WITH BD CONNECTA AND BD Q-SYTE
Type of Device
INTERVASCULAR CATHETER
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
MDR Report Key8906070
MDR Text Key154736910
Report Number9610847-2019-00523
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 09/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date02/28/2021
Device Catalogue Number383661
Device Lot Number8058799
Date Manufacturer Received07/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-